Combination Therapy Development
Combination Therapy Development is a research methodology in drug development that involves the systematic design and evaluation of multiple therapeutic agents to achieve enhanced efficacy, reduced resistance, or improved safety compared to monotherapies.
42
Publications
2.4K
Citations
250
Authors
133
Institutions
Publications per year
2017–2026
15
Parents
42
Structure-guided combination therapy to potently improve the function of mutant CFTRs
Guido Veit, Haijin Xu, Elise Dréano et al. · Nature Medicine · 2018 · 139 citations
1–5 of 42
250
3
h-index
2
h-index
The University of Texas MD Anderson Cancer Center, United States
1 publications · 10 citations
1
h-index
1
h-index
1
h-index
1–5 of 250
133
University of Pennsylvania
Philadelphia, United States
3 h-index
3 publications
382 citations
Ludwig-Maximilians-Universität München
Munich, Germany
3 h-index
3 publications
82 citations
University of Pittsburgh
Pittsburgh, United States
2 h-index
5 publications
203 citations
Inserm
Paris, France
2 h-index
4 publications
439 citations
National Institute of Neurological Disorders and Stroke
Bethesda, United States
2 h-index
2 publications
318 citations
Boston University
Boston, United States
2 h-index
4 publications
101 citations

Johns Hopkins University
Baltimore, United States
2 h-index
5 publications
96 citations
Dana-Farber Cancer Institute
Boston, United States
2 h-index
9 publications
102 citations
1–8 of 133
Repository · 7 publications · 154 citations
7
h-index
3 publications · 382 citations
3
h-index
NEJM · 2 publications · 302 citations
2
h-index
2 publications · 23 citations
2
h-index
APS · 1 publications · 48 citations
1
h-index
1–5